Literature DB >> 21422882

ACOG Committee Opinion No. 485: Prevention of early-onset group B streptococcal disease in newborns.

.   

Abstract

In 2010, the Centers for Disease Control and Prevention revised its guidelines for the prevention of perinatal group B streptococcal disease. Although universal screening at 35-37 weeks of gestation and intrapartum antibiotic prophylaxis continue to be the basis of the prevention strategy, these new guidelines contain important changes for clinical practice. The Committee on Obstetric Practice endorses the new Centers for Disease Control and Prevention recommendations, and recognizes that even complete implementation of this complex strategy will not eliminate all cases of early-onset group B streptococcal disease.

Entities:  

Mesh:

Year:  2011        PMID: 21422882     DOI: 10.1097/AOG.0b013e318219229b

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  40 in total

1.  High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital.

Authors:  Ephraim E Back; Elisa J O'Grady; Joshua D Back
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Risk factors for infectious disease death among infants in the United States.

Authors:  Marissa K Person; Douglas H Esposito; Robert C Holman; Jason M Mehal; Barbara J Stoll
Journal:  Pediatr Infect Dis J       Date:  2014-11       Impact factor: 2.129

3.  Nontypeable Haemophilus Influenzae Sepsis in a Term Neonate.

Authors:  Saki Okubo; Kazumichi Fujioka; Megumi Yamane; Mariko Ashina; Sachiyo Fukushima; Toshihiko Ikuta; Shohei Ohyama; Keiji Yamana; Akiko Kobayashi; Kazumoto Iijima; Ichiro Morioka
Journal:  Kobe J Med Sci       Date:  2018-04-19

4.  Suggested Modifications To Improve the Sensitivity and Specificity of the 2010 CDC-Recommended Routine Streptococcus agalactiae Screening Culture for Pregnant Women.

Authors:  Hossein Salimnia; Barbara Robinson-Dunn; Angela Gundel; Alicia Campbell; Robert Mitchell; Maureen Taylor; Marilynn R Fairfax
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

5.  Antepartum screening for group B Streptococcus by three FDA-cleared molecular tests and effect of shortened enrichment culture on molecular detection rates.

Authors:  Brianne A Couturier; Trent Weight; Haley Elmer; Robert Schlaberg
Journal:  J Clin Microbiol       Date:  2014-07-09       Impact factor: 5.948

6.  Transplacental passage of clindamycin from mother to neonate.

Authors:  C D Wear; C V Towers; M S Brown; B Weitz; S Porter; L Wolfe
Journal:  J Perinatol       Date:  2016-08-04       Impact factor: 2.521

Review 7.  Birth Mode, Breastfeeding, Pet Exposure, and Antibiotic Use: Associations With the Gut Microbiome and Sensitization in Children.

Authors:  Haejin Kim; Alexandra R Sitarik; Kimberley Woodcroft; Christine Cole Johnson; Edward Zoratti
Journal:  Curr Allergy Asthma Rep       Date:  2019-03-11       Impact factor: 4.806

Review 8.  Reappraisal of guidelines for management of neonates with suspected early-onset sepsis.

Authors:  William E Benitz; James L Wynn; Richard A Polin
Journal:  J Pediatr       Date:  2015-01-29       Impact factor: 4.406

9.  Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin.

Authors:  Judith S Heelan; Meredith E Hasenbein; Alexander J McAdam
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

10.  Hyperinvasive neonatal group B streptococcus has arisen from a bovine ancestor.

Authors:  Naiel Bisharat; Derrick W Crook; James Leigh; Rosalind M Harding; Phil N Ward; Tracey J Coffey; Martin C Maiden; Tim Peto; Nicola Jones
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.